United States

Separating the hype from reality: How specialty pharmaceuticals should address pricing pressures to ensure market access

Wednesday December 14, 2016 1:00 PM - 2:00 PM EST
From Healthcare & Life Sciences Institute

KPMG Healthcare & Life Sciences Institute

Event Overview

Please join KPMG LLP on Wednesday, December 14th, from 1:00 to 2:00 p.m. ET for a special webcast on a topic impacting all major healthcare stakeholders – life sciences companies, healthcare payers and providers, and patients. KPMG market access strategists Peter Gilmore and Any Hunckler will explore how drug pricing pressures are leading to new market access barriers for specialty pharmaceuticals.

Media hype is giving companies a false impression of payer actions that are realistic versus those that are far-fetched. Pharmaceutical organizations investing in breakthrough innovations can hone their focus on those stakeholder pricing pressures that will likely come to fruition and discover how to respond strategically. Webcast attendees will hear more about:

  • Specialty Pharma spending trends and emerging cost of care dynamics
  • The most critical access barriers for consideration during market access launch planning
  • An understanding the of the difference between overblown and realistic concerns related to future pricing pressures
  • Practical examples of how companies are addressing near-term pricing and market access pressures

Attendees will also be able to download a copy of KPMG’s recent thought leadership on this topic – Specialty Drug Market Access Reality Check: Ten Payer Pressures to Act on Now.

The Webcast will last approximately 60 minutes, including a question-and-answer session. 

"Click on the speaker names to view a full bio.”

Pete Gilmore

Principal, KPMG Corporate Strategy

Amy Hunckler

Managing Director, KPMG Corporate Strategy